AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2026 Issue 1; Ask the Editor
Gastroparesis due to Tirzepatide
A nondiabetic patient presents with nausea and vomiting due to gastroparesis from an increased dose of tirzepatide prescribed for weight loss. What are the appropriate ICD-10-CM code assignments for the adverse effect of injecting tirzepatide? ...
Subscribe or sign in to view the full article.
Article Overview
This article discusses ICD-10-CM coding considerations for a nondiabetic patient who develops gastroparesis symptoms associated with tirzepatide prescribed for weight loss. It is intended for coders and billing professionals looking for guidance on how the article frames the relationship between the medication exposure, the adverse effect, and the digestive diagnosis.
Why This Topic Matters
Medication-related adverse effects can affect diagnosis coding and claim accuracy. Understanding the article’s scope helps readers decide whether they need the full guidance on ICD-10-CM assignment for this scenario.
What You Will Learn
- How the article approaches ICD-10-CM coding for a medication-related adverse effect
- How the discussion connects gastroparesis symptoms with tirzepatide exposure
- What general type of coding guidance is provided for this scenario
- How the article frames coding for a GLP-1 medication adverse effect
Who Should Read This
- Medical coders
- Coding auditors
- Billing staff
- Compliance professionals
- Clinical documentation improvement specialists
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com